Chatv0.3

Alpha Tracker

Two stocks. Twice a week. Full thesis. No noise.

Last run: 2026-05-23Next run: 2026-05-26

Not financial advice. Educational AI research only.

Active Positions (4)

STZ
Constellation Brands, Inc.
Entry
$143.56
May 23, 2026
Catalyst
Next quarterly earnings report (Q1 FY2027, expected late June/early July 2026) — beer segment volume stabilization and any upward revision to the heavily-cut FY2026 comparable EPS guidance of $11.30–$11.60 would serve as a major re-rating trigger
Target
$175.00
+21.9%
Stop
$124.00
-13.6%
Conviction
7/10
Bull Case

STZ trades at a significant discount to its 52-week high of $196.91 and carries a median analyst price target of $202, implying ~41% upside from the $143.56 entry — the valuation gap is wide by consumer staples standards. The Q4 FY2026 earnings beat ($1.90 actual vs. $1.71 consensus, +11%) and the subsequent 8.5% stock jump signal that the worst of the guidance-cut cycle may be behind it, and defensive sector rotation (consumer staples up 13.3% YTD) provides a supportive macro backdrop. A stabilization in beer volumes and easing immigration-related demand headwinds could drive rapid multiple re-expansion toward the $175–$202 range.

Bear Case

STZ's beer portfolio is heavily exposed to Mexican imports, and any escalation in tariff policy could directly compress margins, which are already under pressure (TTM profit margin at -0.8% GAAP). Organic net sales guidance was cut dramatically to -4% to -6% from prior +1% to -2%, and non-GAAP EPS declined 14% YoY — the fundamental reset may not yet be complete. If the Hispanic consumer demand headwind deepens or tariff pass-through proves difficult, the stock could break below its 52-week low of $126.45.

DE
Deere & Company
Entry
$559.50
May 23, 2026
Catalyst
Q3 FY2026 earnings release (expected August 2026) — construction & forestry segment momentum and any upward revision to full-year net income guidance of $4.5–5.0B will be the key read-through
Target
$655.00
+17.1%
Stop
$490.00
-12.4%
Conviction
7/10
Bull Case

Deere's construction & forestry segment surged +29% YoY in Q2 FY2026 to $3.79B, driven by AI infrastructure and energy capex tailwinds, providing meaningful insulation from large-ag weakness. The company beat Q2 EPS by 15% ($6.55 vs. $5.70 consensus) and raised net income guidance mid-cycle; management believes 2026 marks the ag cycle bottom, setting up a recovery catalyst in H2. Analyst consensus is Buy (13 Buy, 0 Sell) with a 12-month price target range of $655–$719, implying 17–29% upside from current levels.

Bear Case

Large agriculture equipment demand remains structurally soft — FY2025 net income declined 29% YoY and the segment has not shown meaningful recovery signs yet. A prolonged farm-spending freeze combined with tariff-driven input cost pressures could keep the stock range-bound; the stock already sold off 7% post-Q2 despite the earnings beat, signaling elevated macro sensitivity. If full-year net income guidance is cut below $4.5B, the stock could revisit its 52-week low near $433.

NVDA
NVIDIA Corporation
Entry
$215.33
May 23, 2026
Catalyst
Q2 FY2027 earnings report (expected ~August 2026), where sustained 90%+ data center revenue growth and further record free cash flow would re-rate the multiple higher
Target
$260.00
+20.7%
Stop
$188.00
-12.7%
Conviction
7/10
Bull Case

NVDA's Q1 FY2027 results confirmed AI infrastructure demand is structurally intact: data center revenue surged 92% YoY to $75B, GAAP EPS of $1.87 beat by 6.25%, and record free cash flow of $49B with 74.9% gross margins signal pricing power. At a 27x forward P/E against ~30% annualized earnings growth, the stock trades at a reasonable PEG ratio; any re-acceleration narrative into Q2 earnings could close the gap to the 52-week high of $236.54 and beyond toward $260.

Bear Case

At $5.32T market cap and 21x price-to-sales TTM, NVDA is priced for near-perfection — any slowdown in hyperscaler capex commitments, export control tightening, or macro-driven multiple compression could see the stock revisit the 52-week low range near $129. Elevated Treasury yields remain a structural headwind for long-duration growth assets, and the post-earnings price decline despite a beat signals the market may already be discounting near-term upside.

MDLZ
Mondelēz International, Inc.
Entry
$54.26
May 23, 2026
Catalyst
H2 2026 margin expansion driven by cocoa cost relief, per Morgan Stanley's 'top pick' upgrade with $70 target (raised from $66)
Target
$70.00
+29.0%
Stop
$47.00
-13.4%
Conviction
8/10
Bull Case

MDLZ trades at a significant discount to consumer staples peers — Morningstar rates it 4-star (undervalued) while sector leaders like Walmart and Costco are 1-star. Q1 2026 adjusted EPS of $0.67 beat estimates by 9.6% on +8.3% YoY revenue growth to $10.08B, and Morgan Stanley's top-pick upgrade sets a $70 target on the back of cocoa price normalization driving meaningful gross margin recovery in H2 2026. The median analyst target of $70 implies ~29% upside from current levels within 6 months.

Bear Case

MDLZ carries significant international exposure, making it vulnerable to tariff-driven input cost inflation that could offset cocoa tailwinds and compress margins further. The GAAP net margin is already thin at 6.6% TTM, leaving little buffer if macro volatility escalates or FX headwinds intensify in emerging markets. Management's decision to hedge upside guidance for reinvestment rather than raising targets suggests near-term earnings revision risk remains limited.

Disclaimer

This is a paper-trading exercise for educational purposes only. Nothing published here constitutes investment advice. Past simulated performance has no bearing on future real returns. Every number shown must have a source URL — if no sources appear on a card, the pick was rejected before publication.